Of the 160 ovarian cancer samples, a quarter of them (24.2%) were scored 0 for BubR1 immunostaining and about 30% scored 0 for Aurora A, whereas normal specimens scored 0 in all cases (Table 2, Figure 2). Here, BUB1B is linked to ovarian cancer.